Anmeldung erfolgt in Kürze...
Details werden geladen...
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up to $2.13 billion.
Ähnliche Seiten
PETA and Nick Cave launch special charity merchandise range
https://faroutmagazine.co.uk/peta-nick-cave-merchandise-range-celebrate-69th-birthday/
Raytheon to build record numbers of AMRAAM missiles
https://defence-blog.com/raytheon-to-build-record-numbers-of-amraam-missiles/
European consumer protection authorities ramp up action to protect gamers' rights - EUbusiness.com | EU news, business and politics
https://www.eubusiness.com/consumer/european-consumer-protection-authorities-to-protect-gamers-rights/
Dangote, Ruto to launch $16 billion Kenya refinery amid land protests
https://www.premiumtimesng.com/business/business-news/913575-dangote-ruto-to-launch-16-billion-kenya-refinery-amid-land-protests.html
TomTom Expands Collaboration With Microsoft Fabric To Power AI Agents With Real-world Context | 30.09.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/tomtom-expands-collaboration-with-microsoft-fabric-to-power-ai-agents-with-real-world-context-1036584329